EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Recent developments in eosinophilic renal neoplasms: what's new, true and important?

Kiril Trpkov iD, Farshid Siadat iD, Rola Saleeb iD

Histopathology · 2026-01 · 88 (1) · 166-192

DOI: 10.1111/his.70001 ↗

At a glance

Übersichtsarbeit in Histopathology, published online on 2025-12-12. Written by Kiril Trpkov and 2 co-authors. Institution: Diagnostic and Molecular Pathology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Major MEDLINE topics: Kidney Neoplasms, Carcinoma, Renal Cell. Cited 8 times so far (Crossref); 211 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

We focus in this review on the latest developments on several eosinophilic renal entities, aiming to provide an update on this topic that was previously addressed by the Genitourinary Pathology Society in their consensus papers on existing renal entities, and on novel, emerging, and provisional renal entities, and in the World Health Organization 2022 Classification of Renal Cell Tumours (5th Edition). The scope of this review includes an update on more recently described eosinophilic renal entities, including low‐grade oncocytic renal tumour (LOT), eosinophilic vacuolated tumour (EVT), folliculin ( FLCN ) mutated tumour, succinate dehydrogenase (SDH)‐deficient renal cell carcinoma, epithelioid angiomyolipoma/epithelioid PEComa (eAML/ePEComa), eosinophilic solid and cystic renal cell carcinoma (ESC RCC), anaplastic lymphoma kinase (ALK)‐rearranged RCC, fumarate hydratase (FH)‐deficient RCC, papillary renal neoplasm of reversed polarity (PRNRP), tubulocystic RCC (TC‐RCC), and thyroid‐like follicular carcinoma of kidney (TLFCK). These renal entities fall within the spectrum of eosinophilic renal tumours, in addition to the more common ones with eosinophilic features that will not be covered in this review, such as clear cell renal RCC, papillary RCC, chromophobe RCC, TFE3 rearranged RCC, and TFEB‐altered RCC. Pathologists need to consider these less common renal entities in the differential of any eosinophilic renal tumour to be able to diagnose them for the benefit of their patients. The recent developments and acquired knowledge on newer renal entities with eosinophilic cytoplasm opened insights into the clinical, pathological, immunohistochemical, molecular, epidemiological aspects, and the prognosis of these entities. We emphasize the role of routine morphology, aided by appropriate and select immunohistochemistry, as essential keys for diagnosing eosinophilic renal tumours.

Subjects

MeSH terms (MEDLINE)

Kidney NeoplasmsCarcinoma, Renal CellHumans

Author keywords

RCCemerging renal entityeosinophilic renal tumourkidneynew renal entityrenal cell carcinoma

Authors and institutions

  • Diagnostic and Molecular Pathology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

ORCID profiles: Kiril Trpkov, Farshid Siadat, Rola Saleeb

Cite

APA

Trpkov, K., Siadat, F., & Saleeb, R. (2026). Recent developments in eosinophilic renal neoplasms: what's new, true and important?. Histopathology, 88(1), 166-192. https://doi.org/10.1111/his.70001

Vancouver

Trpkov K, Siadat F, Saleeb R. Recent developments in eosinophilic renal neoplasms: what's new, true and important?. Histopathology. 2026;88(1):166-192. doi:10.1111/his.70001

BibTeX
@article{Trpkov2026,
  author = {Trpkov, Kiril and Siadat, Farshid and Saleeb, Rola},
  title = {Recent developments in eosinophilic renal neoplasms: what's new, true and important?},
  journal = {Histopathology},
  year = {2026},
  volume = {88},
  number = {1},
  pages = {166--192},
  doi = {10.1111/his.70001}
}
Start for free →